A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
about
The management of glaucoma and intraocular hypertension: current approaches and recent advancesMeta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertensionEffects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeabilityThe outcome of mitomycin C trabeculectomy and laser suture lysis depends on postoperative management.Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.Performing meta-analysis with incomplete statistical information in clinical trialsRecent advances in pharmacotherapy of glaucomaClinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionTherapeutic potential of prostaglandin analogues in glaucoma.Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish LaAdditive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.Prostanoids in the therapy of glaucoma.Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost.A review of the use of latanoprost for glaucoma since its launch.Topical latanoprost causes posterior movement of lens in a patient with exfoliation syndrome and subluxated lens: a case report.The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.The latanoprost monotherapy survey in New Zealand, 2000.Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study.A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma.Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients.Efficacy and safety of latanoprost in eyes with uveitic glaucoma.The additive effects on intraocular pressure of combining nipradilol 0.25% and latanoprost 0.005% ophthalmic solutions: a prospective, randomized, multicenter study.Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients.The Effect of Latanaprost on Intraocular Inflammation and Macular Edema.Association between glaucoma eye drops and hyperemia.Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
P2860
Q22305849-03937278-455A-4E7D-AF88-1BD54047BAAEQ24672885-82250223-EBD6-4336-9E68-88AC82A70351Q28379588-31D5F6AD-BFFC-4687-993B-590D336E199AQ30827359-612D8517-2FB8-4281-9CA9-352222CD6DE3Q31890726-67CB5833-BBC9-4992-941E-564F4C06F7A0Q33360471-A117F334-9A57-442E-8258-6FA8822CEA06Q33521178-70676ED9-D97D-4F75-9C43-2AC62EE75729Q34043309-A98CE946-9620-4275-B5C4-CA097982A9E0Q34204357-887A90C5-DF4E-4D98-B603-883196836950Q34996623-AD66D55D-A128-40C1-A49B-66972C59661CQ35237431-838098DB-3F8D-4926-B35D-ADC8AE69BF3BQ35313371-3FFA058D-A8F7-4A82-91B6-5D6B9EF71BAFQ35589367-AD7FFC6A-4F00-4EE6-B107-419428AD8925Q35592180-1F3EA422-EC16-4E7C-93B5-0F7E385F712CQ35894656-190CE3B9-03C2-4F56-8CE8-F71AF643925CQ35987460-4418C988-09A0-4069-97B4-E1B982F17D65Q36580774-E14C98D9-6625-417A-9158-5C0A2C2D5E1EQ36856440-1981BB49-F877-4499-B1DD-69BFAFA54B6DQ37086961-8ADBF2A6-2FE9-4EDD-91ED-C62AE2FA3DF8Q37288768-42DC55F5-DFE6-4654-9938-BB53B230E48EQ37986149-FB79CA6D-8FF2-42E3-BE7A-61EE14FA1682Q41852560-B2E778BD-7417-42A8-9A47-C47D9D980C1EQ43563756-23DD91D0-4130-43A0-974C-2397B2F0CC40Q43846181-5BB63F19-3E22-421B-A254-55416BB701C6Q43848491-9709D2E3-5262-4293-B664-45D852D19C34Q44251158-6B0F3282-07D2-423C-BFA8-E53E35D9970EQ44461407-826BEB34-06E5-4BC6-9B83-7ED37D257E45Q44810295-63349976-74DC-405E-A73E-188848779268Q46138251-C3C95743-651D-45A5-B52E-8E8B99E8AA32Q46259328-326DC077-5845-4339-B322-2C3E8E2DDF3AQ46923932-A8119D3D-0170-4C12-86CD-69D0CC5DB951Q48189546-95AFA411-89B6-4345-A9C3-D729823126D4Q52985172-661A0955-5435-404A-BE6A-6F6D861564CBQ58549621-109E4EA2-DD04-4A96-B65A-2D40289B4473
P2860
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A comparison of latanoprost an ...... hypertension. A 12-week study.
@en
A comparison of latanoprost an ...... hypertension. A 12-week study.
@nl
type
label
A comparison of latanoprost an ...... hypertension. A 12-week study.
@en
A comparison of latanoprost an ...... hypertension. A 12-week study.
@nl
prefLabel
A comparison of latanoprost an ...... hypertension. A 12-week study.
@en
A comparison of latanoprost an ...... hypertension. A 12-week study.
@nl
P2093
P1433
P1476
A comparison of latanoprost an ...... hypertension. A 12-week study.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1996.01100140137004
P407
P577
1996-08-01T00:00:00Z